IP Library Patent Application 14535220
Patent Application
App. No. 14/535,220

INJECTABLE MONOPHASE HYDROGELS

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
14/535,220
Abstract

An injectable monophase hydrogel is provided and is made of a reaction mixture of a high molecular weight hyaluronic acid and a low molecular weight hyaluronic acid.

Claims (23)

1 . An injectable product useful as a filling material in plastic or cosmetic surgery, the hydrogel comprising:

a homogenous, monophase injectable hydrogel comprising crosslinked hyaluronic acid and made from a reaction mixture comprising a low molecular weight hyaluronic acid and a high molecular weight hyaluronic acid.

2 . The product of claim 1 wherein the low molecular weight hyaluronic acid has a molecular weight m of ≦9.9×10 5 Da.

3 . The product of claim 1 wherein the low molecular weight hyaluronic acid has a molecular weight m of 10 4 Da≦m 9.9×10 5 Da.

4 . The product of claim 1 wherein the high molecular weight hyaluronic acid has a molecular weight M of ≧10 6 Da.

5 . The product of claim 1 wherein the high molecular weight hyaluronic acid has a molecular weight M of 10 6 Da≦M≦10 8 Da.

6 . The product of claim 1 wherein the high molecular weight hyaluronic acid has a molecular weight M of 1.1×10 6 Da≦M≦5×10 6 Da.

7 . The product of claim 1 wherein the reaction mixture has an intrinsic viscosity of less than 1900 ml/g.

8 . The product of claim 1 wherein the reaction mixture contains more than 50% by weight of the low molecular weight hyaluronic acid.

9 . The product of claim 1 wherein the reaction mixture contains more than 70% by weight of the low molecular weight hyaluronic acid.

10 . The product of claim 1 wherein the reaction mixture contains 90% by weight of the low molecular weight hyaluronic acid.

11 . The product of claim 1 wherein the reaction mixture contains at least 5% by weight of the high molecular weight hyaluronic acid.

12 . The product of claim 1 that is manually injectable through a hypodermic needle having a needle gauge selected from one of 30 G, 27 G, 26 G and 25 G.

13 . The product of claim 1 that is injectable through a hypodermic needle of 27 G.

14 . The product of claim 1 having a hyaluronic acid concentration between 10 mg/g and 40 mg/g.

15 . The product of claim 1 having a hyaluronic acid concentration between 20 mg/g and 30 mg/g.

16 . An injectable composition useful as a filling material in plastic or cosmetic surgery, the composition comprising:

a homogenous, monophase injectable hydrogel comprising a crosslinked hyaluronic acid;

the hydrogel made using a mixture containing at least 50% of a low molecular weight hyaluronic acid salt and a sufficient amount of a high molecular weight hyaluronic acid salt to obtain a coherent crosslinked compostion that is the precursor of the monophase injectable hydrogel.

17 . The composition of claim 16 wherein the hydrogel has a hyaluronic acid concentration between 10 mg/g and 40 mg/g.

18 . The composition of claim 17 wherein the mixture contains at least 5% by weight of the high molecular weight hyaluronic acid salt.

19 . The composition of claim 17 that is manually injectable through a hypodermic needle having a needle gauge selected from one of 30 G, 27 G, 26 G and 25 G.

20 . The composition of claim 17 that is injectable through a hypodermic needle of 27 G.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 10, 2015
From: LEBRETON, PIERRE
To: CORNEAL INDUSTRIE
Reel/Frame 034928/0814 →
CHANGE OF NAME Recorded Feb 10, 2015
From: CORNEAL INDUSTRIE SAS
To: ALLERGAN INDUSTRIES SAS
Reel/Frame 034934/0757 →